3/12/2025Pfizer's PD-L1 Targeting ADC Receives Clinical Trial Approval in China

3/12/2025Eli Lilly Plans Late 2025 Launch of Weight Loss Drugs in China and Ind...

3/12/2025CSPC Advances Phase II Trial of Nectin-4 ADC SYS6002 for Advanced HNSC...

3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...

3/11/2025Over 100 Chinese Pharma Firms Report Losses as 319 Firms Release 2024 ...

3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...

3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...

3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...

3/11/2025Juvensis Secures Over CNY 100M in Pre-A Financing to Advance Gene The...

3/11/2025RockRoc Secures Pre-A+ Financing to Advance Macrophage-Based Cancer Th...

3/11/2025InnoCare Presents Promising Phase II Data on ICP-488 for Psoriasis

3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...

3/10/2025Nona Bio Launches AI-Assisted Drug Discovery Platform Hu-mAtrIx

3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment

3/10/2025China Expands BMI Coverage to Over 90% of Village Clinics

3/10/2025China's Life Expectancy Reaches 79 Years in 2024, Surpassing Health Pl...

3/10/2025China to Expand Mental Health Services Nationwide: Official

3/7/2025Recent Executive Moves

3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...

3/7/2025Enhua Pharma Acquires 10.4% Stake in NeuroThree with $3.5M Investment...

3/7/2025CStone Submits Clinical Trial Application in Australia for CS5001 in D...

3/6/2025Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline  

3/6/2025Bayer Expands Innovation in China with New E-Town Center

3/5/2025China to Adjust Centralized Drug Procurement Policies

3/5/2025CStone Announces First Patient Dosed in Global Trial of Trispecific An...

3/4/2025Hansoh Pharma's HS-20089 Advances to Phase III Trial for Platinum-Resi...

3/4/2025Bioray's BR111: Pioneering Dual-Epitope ADC for ROR1-Positive Cancers

3/4/2025Longbio Pharma's LP-003 Shows Promising Results in Phase II CSU Trial

3/4/2025The United Labs' UBT251 Injection Receives FDA Approval for Phase II C...

3/4/2025BeiGene's TEVIMBRA Approved in U.S. for First-line Treatment of Advanc...

Page:19/53 Total number of articles:1564: [First][<<] [17] [18] [19] [20] [21] [>>] [End]